Acta Neuropathologica Submission Guide

Source: Clarivate JCR 2024, Springer Nature editorial disclosures (accessed April 2026).

Source: Acta Neuropathologica author guidelines.

Use this page when deciding:

• whether the contribution is mechanistic or translational
• whether the tissue cohort is adequate
• whether molecular characterization is appropriate

• a clear mechanistic or translational contribution
• adequate tissue cohort for the research question
• molecular characterization (genomic, proteomic, histological)
• connection to neurological disease understanding
• a cover letter establishing the mechanistic contribution

• Descriptive case reports without mechanistic insight.
• Limited tissue cohorts.
• Missing molecular characterization.
• Clinical neurology without neuropathology focus.

Acta Neuropathologica is among the highest-impact neuropathology journals.

Mechanism-first standard: the journal differentiates from Brain Pathology (broader) and Neuropathology and Applied Neurobiology (more applied) by demanding mechanistic insight.

Molecular-characterization expectation: editors expect molecular-level analysis appropriate to the research question.

The 50-60% desk rejection rate: decisive editorial screen.

The strongest Acta Neuropathologica cover letters establish:

• the mechanistic contribution
• the tissue cohort and molecular characterization
• the translational relevance
• the central finding

• Is Acta Neuropathologica a good journal?

Before upload, run your manuscript through an Acta Neuropathologica mechanism readiness check.

In our pre-submission review work with neuropathology manuscripts targeting Acta Neuropathologica, three patterns generate the most consistent desk rejections.

In our experience, roughly 35% of Acta Neuropathologica desk rejections trace to descriptive case-report framing. In our experience, roughly 25% involve limited tissue cohorts. In our experience, roughly 20% arise from missing molecular characterization.

• Descriptive case reports without mechanistic insight. Acta Neuropathologica editors look for mechanistic understanding, not just case descriptions. We observe submissions framed as case reports without mechanistic experiments routinely desk-rejected unless they describe a novel disease entity with comprehensive characterization.

• Limited tissue cohorts without justification. Editors expect adequate cohort size for the research question. We see manuscripts with small cohorts and no power justification routinely returned with cohort-expansion requests.

• Missing molecular characterization. Acta Neuropathologica specifically expects molecular-level analysis. We find papers with histological description without molecular characterization (genomic, proteomic, immunohistochemistry beyond standard markers) routinely declined. An Acta Neuropathologica mechanism readiness check can identify whether the package supports a submission.

Clarivate JCR 2024 bibliometric data places Acta Neuropathologica among top neuropathology journals.

In pre-submission diagnostic work for top neuropathology journals, we consistently see four signals that distinguish strong submissions from weak ones. First, the contribution must be mechanistic or translational, not descriptive; submissions framed as case descriptions without mechanism fail at desk screening. Second, tissue cohorts should be adequate for the research question with explicit power justification. Third, molecular characterization should be appropriate to the question, including genomic, proteomic, or quantitative immunohistochemistry analysis. Fourth, the neuropathology focus should be primary; clinical neurology studies fit specialty venues better.

The single most consistent feedback class we deliver in pre-submission diagnostics for Acta Neuropathologica is the descriptive-versus-mechanistic distinction. Acta Neuropathologica editors expect mechanistic understanding, not just neuropathological observations. Submissions framed as "we describe the histological features of disease X in patient cohort Y" routinely receive "where is the mechanism?" feedback during desk screening. We coach authors to lead with the mechanistic question and frame the tissue analysis in service of that question. Papers framed as "we tested whether mechanism X drives the neuropathological feature Y by combining histology with molecular analysis Z" receive better editorial traction. The same logic applies across mechanism-focused neuropathology journals: editors are operating with limited slot inventory, and the submissions that get traction lead with the mechanism question.

Beyond the rubric checks, three pre-submission diagnostic patterns recur most often in the manuscripts we review for Acta Neuropathologica. First, manuscripts where the abstract reports histological observations without articulating the mechanism are flagged at desk for descriptive framing. We recommend the abstract's central sentences state the mechanistic question, the experimental approach, and the molecular finding. Second, manuscripts where tissue-cohort characteristics are reported without statistical-power justification are flagged for cohort concerns. We recommend explicitly stating cohort size, ascertainment criteria, and statistical-power justification. Third, manuscripts that lack engagement with Acta Neuropathologica's recent issues are at risk of being told the contribution doesn't fit the publication conversation.